equasym retard 10 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 10 mg - metyylifenidaatti
equasym retard 20 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 20 mg - metyylifenidaatti
equasym retard 30 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 30 mg - metyylifenidaatti
equasym retard 40 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 40 mg - metyylifenidaatti
equasym retard 50 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 50 mg - metyylifenidaatti
equasym retard 60 mg depotkapseli, kova
takeda pharmaceuticals international ag ireland branch - methylphenidate hydrochloride - depotkapseli, kova - 60 mg - metyylifenidaatti
ketocal 50 mg kapseli
pharmacal oy ab - ketoprofenum - kapseli - 50 mg - ketoprofeeni
ketocal 100 mg kapseli
pharmacal oy ab - ketoprofenum - kapseli - 100 mg - ketoprofeeni
ketocal 100 mg peräpuikko
pharmacal oy ab - ketoprofenum - peräpuikko - 100 mg - ketoprofeeni
nexviadyme
sanofi b.v. - avalglucosidase alfa - glykogeenin varastointitaudin tyyppi ii - muut ruuansulatuselimistön sairauksien ja aineenvaihduntasairauksien lääkkeet, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).